We are live on ! Find out more
JSPR icon

Jasper Therapeutics
JSPR

57 hedge funds and large institutions have $82.2M invested in Jasper Therapeutics in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

8% more funds holding

Funds holding: 53 → 57 (+4)

0% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 14

1% less capital invested

Capital invested by funds: $82.7M → $82.2M (-$520K)

Holders
57
Holders Change
+4
Holders Change %
+7.55%
% of All Funds
0.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
14
Reduced
14
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WRBC
W.R. Berkley Corp
Connecticut
+$4.35M
2
MSU
Mizuho Securities USA
New York
+$3.93M
3
KKRC
Kohlberg Kravis Roberts & Co
New York
+$3.25M
4
KPF
K2 Principal Fund
Ontario, Canada
+$1.99M
5
BRF
B. Riley Financial
California
+$1.24M

Top Sellers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
-$9.84M
2
SRCM
Sage Rock Capital Management
New York
-$4.59M
3
PMAM
Picton Mahoney Asset Management
Ontario, Canada
-$2.73M
4
MP
Mangrove Partners
Connecticut
-$2.09M
5
LA
Linden Advisors
New York
-$1.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
26
Prelude Capital Management
New York
$1M – – –
PC
27
Periscope Capital
Ontario, Canada
$998K – – –
PMAM
28
Picton Mahoney Asset Management
Ontario, Canada
$993K -$2.73M -27,506 -73%
AA
29
AQR Arbitrage
Connecticut
$980K +$666K +6,701 +213%
Millennium Management
30
Millennium Management
New York
$909K +$701K +7,051 +337%
Citadel Advisors
31
Citadel Advisors
Florida
$859K -$111K -1,114 -11%
LCM
32
Landscape Capital Management
New Jersey
$844K +$844K +8,489 New
YCM
33
Yakira Capital Management
Connecticut
$828K – – –
EAM
34
Exos Asset Management
New York
$602K -$49.9K -502 -8%
GCL
35
Glazer Capital LLC
New York
$590K -$9.84M -99,060 -94%
Walleye Trading
36
Walleye Trading
New York
$578K +$107K +1,077 +23%
CCM
37
Context Capital Management
California
$497K – – –
SAM
38
Seelaus Asset Management
New Jersey
$453K -$4.97K -50 -1%
D.E. Shaw & Co
39
D.E. Shaw & Co
New York
$443K +$442K +4,448 New
WC
40
Wealthspring Capital
New York
$430K – – –
SMA
41
Sage Mountain Advisors
Georgia
$355K – – –
HF
42
HRT Financial
New York
$343K – – –
CAPTRUST Financial Advisors
43
CAPTRUST Financial Advisors
North Carolina
$221K -$19.9K -200 -8%
Citigroup
44
Citigroup
New York
$199K – – –
EIP
45
Easterly Investment Partners
Massachusetts
$199K – – –
COPPSERS
46
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$193K -$304K -3,060 -61%
WAM
47
Wolverine Asset Management
Illinois
$188K -$8.55K -86 -4%
DIG
48
DeepCurrents Investment Group
New York
$157K -$51.8K -521 -25%
MAM
49
Marquette Asset Management
Minnesota
$135K – – –
DWM
50
Dakota Wealth Management
Florida
$132K +$132K +1,330 New
1
2
3

JSPR Hedge Fund Activity: Q2 2021 in Review

57 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Jasper Therapeutics (JSPR) for Q2 2021, worth a combined $82.2M — down 0.63% from $82.7M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new JSPR positions and 5 closed out — a net gain of 4 holders — while 14 added to existing stakes and 14 trimmed.

The largest buyer was W.R. Berkley Corp, opening a new position worth an estimated $4.35M. The largest seller was Glazer Capital LLC, cutting an estimated $9.84M.

  • 57 institutional investors held Jasper Therapeutics (JSPR) as of Q2 2021, up from 53 in Q1 2021.
  • Funds reported $82.2M of Jasper Therapeutics stock for Q2 2021, down 0.63% quarter-over-quarter.
  • 9 funds opened new Jasper Therapeutics positions in Q2 2021 and 5 closed out, a net change of +4 holders.
  • The largest Jasper Therapeutics buyer in Q2 2021 was W.R. Berkley Corp, an estimated $4.35M added.
  • The largest Jasper Therapeutics seller in Q2 2021 was Glazer Capital LLC, an estimated $9.84M sold.

Based on aggregated 13F filings for Q2 2021.